SRPT
SAREPTA THERAPEU
Health Care·Biotechnology·UNITED STATES
$22.50
MCap —
as of 2026-09-04
Total
C2w
Fund
D1w
Quant
B1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
-0.86
Sentiment 88.0%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$22.50
Adaptive Mean
$23.15
-0.65 vs mean
Adaptive σ
0.38
MIDOS BB
$22.39 – $23.91
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
+0.34
ROE
-9.5%
Z +0.16
Rev Gr
-34.3%
Z -0.32
EPS Gr
—
Z +0.03
OPM Gr
-5.9%
Z +1.16
FCF Yld
0.9%
Z +0.46
EPS Surp
0.3%
Z +0.98
EPS 3mo Δ
423.4%
Z -0.08
Fwd P/E
8.76
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
14.47
Q6M
3.66
Q12M
1.46
MA 30/100
1.007
Bullish (MA30 > MA100)
α (Jensen)
1.4632
β (12M)
2.08
σ (12M)
0.809
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
87%
Q Percentile
55%
Divergence
+31.3
Tier
RELOAD — ACT
Fundamentals well ahead of momentum. Strong reload candidate when momentum inflects.
Kirkpatrick RS & Persistence
RS
28.6
RS Pctl
87%
RS Decile
D9
Persistence
2w
at grade C
Options / OI Analysis
No options or Williams data available for this ticker.